4.7 Article

PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up

Cristina Barale et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)

Article Pharmacology & Pharmacy

Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects

Roberto Carnevale et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Article Cardiac & Cardiovascular Systems

PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages

Zufeng Ding et al.

CARDIOVASCULAR RESEARCH (2018)

Article Cardiac & Cardiovascular Systems

Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A(2) Proves Renal Origins of Urinary PGI-M and TX-M

Jane A. Mitchell et al.

CIRCULATION RESEARCH (2018)

Letter Cardiac & Cardiovascular Systems

PCSK9 as a Positive Modulator of Platelet Activation

Marina Camera et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study

Eliano P. Nayarese et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Editorial Material Cardiac & Cardiovascular Systems

Exploration of PCSK9 as a Cardiovascular Risk Factor Is There a Link to the Platelet?

Paul A. Gurbel et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Daniele Pastori et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Review Peripheral Vascular Disease

PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies

Petra El Khoury et al.

CURRENT ATHEROSCLEROSIS REPORTS (2017)

Article Cardiac & Cardiovascular Systems

Cross-talk between LOX-1 and PCSK9 in vascular tissues

Zufeng Ding et al.

CARDIOVASCULAR RESEARCH (2015)

Article Cardiac & Cardiovascular Systems

LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism

Roberto Carnevale et al.

ATHEROSCLEROSIS (2014)

Article Hematology

Inherited Human gp91phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction

Pasquale Pignatelli et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)

Article Biochemistry & Molecular Biology

p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases

Jamel El-Benna et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2009)

Article Biochemistry & Molecular Biology

LDL are oxidatively modified by platelets via GP91phox and accumulate in human monocytes

R. Carnevale et al.

FASEB JOURNAL (2007)

Article Critical Care Medicine

Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients

A Emelyanov et al.

CHEST (2001)

Article Biochemistry & Molecular Biology

Activation-dependent surface expression of LOX-1 in human platelets

MY Chen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)